X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (177) 177
middle aged (120) 120
female (113) 113
male (110) 110
adult (105) 105
index medicus (102) 102
hematology (100) 100
aged (88) 88
transplantation (74) 74
oncology (67) 67
treatment outcome (54) 54
multiple myeloma (48) 48
chemotherapy (44) 44
hematology, oncology and palliative medicine (40) 40
multiple myeloma - drug therapy (40) 40
recurrence (40) 40
antineoplastic combined chemotherapy protocols - therapeutic use (39) 39
therapy (37) 37
transplantation, autologous (35) 35
article (34) 34
bortezomib (34) 34
immunology (33) 33
disease-free survival (32) 32
stem cells (32) 32
hematopoietic stem cell transplantation (31) 31
multiple myeloma - therapy (31) 31
aged, 80 and over (30) 30
survival analysis (29) 29
adolescent (27) 27
antineoplastic agents - therapeutic use (27) 27
retrospective studies (26) 26
cancer (25) 25
care and treatment (25) 25
survival rate (25) 25
hematopoietic stem cells (24) 24
hematopoietic stem cell transplantation - methods (23) 23
multiple myeloma - mortality (23) 23
transplantation, homologous (21) 21
immunotherapy (20) 20
stem cell transplantation (20) 20
stem-cell transplantation (20) 20
thalidomide (20) 20
abridged index medicus (19) 19
bone marrow (18) 18
bone-marrow transplantation (18) 18
clinical trials (18) 18
combined modality therapy (18) 18
cyclophosphamide (18) 18
multiple myeloma - pathology (18) 18
survival (18) 18
versus-host-disease (18) 18
hematopoietic stem cell transplantation - adverse effects (17) 17
leukemia (17) 17
young adult (17) 17
prognosis (16) 16
dexamethasone (15) 15
follow-up studies (15) 15
patient outcomes (15) 15
research (15) 15
bone-marrow-transplantation (14) 14
boronic acids - therapeutic use (14) 14
hemic and lymphatic diseases (14) 14
medicine, general & internal (14) 14
pyrazines - therapeutic use (14) 14
analysis (13) 13
health aspects (13) 13
high-dose chemotherapy (13) 13
multiple myeloma - immunology (13) 13
myeloma (13) 13
non-hodgkins-lymphoma (13) 13
relapse (13) 13
thalidomide - analogs & derivatives (13) 13
antibodies, monoclonal - therapeutic use (12) 12
bone-marrow (12) 12
dexamethasone - administration & dosage (12) 12
disease progression (12) 12
prospective studies (12) 12
remission induction (12) 12
risk factors (12) 12
t cells (12) 12
acute disease (11) 11
antineoplastic agents - adverse effects (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (11) 11
autografts (11) 11
bone marrow transplantation (11) 11
child (11) 11
melphalan (11) 11
multiple-myeloma (11) 11
risk (11) 11
acute myeloid-leukemia (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
autologous transplantation (10) 10
boronic acids - adverse effects (10) 10
lenalidomide (10) 10
lenalidomide plus dexamethasone (10) 10
lymphoma (10) 10
mortality (10) 10
pyrazines - adverse effects (10) 10
surgery (10) 10
thalidomide - administration & dosage (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 12/2016, Volume 2016, Issue 1, pp. 521 - 527
Allogeneic hematopoietic cell transplantation and donor lymphocyte infusion for multiple myeloma (MM) can induce graft-versus-myeloma immunity and long-term... 
Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Multiple Myeloma - therapy | Animals | Humans | Multiple Myeloma - immunology | Receptors, Antigen, T-Cell - immunology | Adoptive Transfer | Cell- and Tissue-Based Therapy | Immunologic Factors - therapeutic use | Myeloma | Immunotherapy
Journal Article
Nature Medicine, ISSN 1078-8956, 08/2015, Volume 21, Issue 8, pp. 914 - 921
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1770 - 1781
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2005, Volume 352, Issue 24, pp. 2487 - 2498
Journal Article
Blood, ISSN 0006-4971, 08/2013, Volume 122, Issue 6, pp. 863 - 871
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 13, pp. 1195 - 1203
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 21, pp. 2133 - 2142
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2015, Volume 126, Issue 20, pp. 2284 - 2290
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 2, pp. 135 - 145
Blocking lymphocyte chemotaxis with an oral inhibitor of the CCR5 receptor was associated with reduced incidence of visceral graft-versus-host disease (GVHD)... 
MEDICINE, GENERAL & INTERNAL | HEMATOPOIETIC-CELL TRANSPLANTATION | BONE-MARROW-TRANSPLANTATION | ACUTE GVHD | UNRELATED DONORS | CLINICAL-TRIALS | PREPARATIVE REGIMENS | HEMATOLOGIC MALIGNANCIES | CHEMOKINE RECEPTOR CCR5 | R5 HIV-1 INFECTION | T-CELLS | Hematologic Neoplasms - therapy | T-Lymphocytes - physiology | Triazoles - adverse effects | Cyclohexanes - pharmacology | Humans | Middle Aged | Male | Graft vs Host Disease - immunology | Chemokine CCL3 - antagonists & inhibitors | Chemokine CCL5 - antagonists & inhibitors | Transplantation, Homologous | Young Adult | Cyclohexanes - therapeutic use | Chemotaxis, Leukocyte - drug effects | Graft vs Host Disease - mortality | T-Lymphocytes - drug effects | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Cyclohexanes - adverse effects | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Kaplan-Meier Estimate | Triazoles - pharmacology | Graft vs Host Disease - prevention & control | Aged | Drugs | Dose-response relationship (Biochemistry) | Maraviroc | Lymphocytes | Physiological aspects | Graft versus host reaction | Dosage and administration | Product/Service Evaluations | Research | Drug therapy | Health aspects | Chemokine receptors | Graft-versus-host reaction | CCR5 protein | Transplants & implants | Risk groups | Liver | Prophylaxis | Stem cell transplantation | Lymphocytes T | Chemotaxis | Hemopoiesis | Human immunodeficiency virus--HIV | Internalization | Bone marrow
Journal Article